LEN
30
-3
A
48
8
WM
57
-2
STZ
44
-3
DE
43
-3
AAP
1
-4
VNO
50
-2
TJX
62
-3
CAH
60
2
DHR
64
2
AVY
54
-7
FDX
61
11
GIS
60
3
VIX
32
-12
ORCL
26
2
HPQ
35
-4
MUR
33
-5
XRX
38
-3
CMA
65
-6
AMAT
49
2
LEN
30
-3
A
48
8
WM
57
-2
STZ
44
-3
DE
43
-3
AAP
1
-4
VNO
50
-2
TJX
62
-3
CAH
60
2
DHR
64
2
AVY
54
-7
FDX
61
11
GIS
60
3
VIX
32
-12
ORCL
26
2
HPQ
35
-4
MUR
33
-5
XRX
38
-3
CMA
65
-6
AMAT
49
2
Financhill
Back

iShares US Pharmaceuticals ETF Stock Predictions

14K Investors Got In Earlier. You Still Can.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
68

IHE
iShares US Pharmaceuticals ETF

Last Price:
$84.92
Seasonality Move:
1.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Share Price Moved. Momentum Hasn't Slowed.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

iShares US Pharmaceuticals ETF Stock Forecast

  • Over the next 52 weeks, iShares US Pharmaceuticals ETF has on average historically risen by 9.5% based on the past 19 years of stock performance.
  • iShares US Pharmaceuticals ETF has risen higher in 14 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 73.68%
  • Is iShares US Pharmaceuticals ETF Stock Undervalued?
    The current iShares US Pharmaceuticals ETF [IHE] share price is $84.26. The Score for IHE is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • IHE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will iShares US Pharmaceuticals ETF Stock Go Up Next Year?

  • Over the next 52 weeks, iShares US Pharmaceuticals ETF has on average historically risen by 9.5% based on the past 19 years of stock performance.

iShares US Pharmaceuticals ETF Stock Rating

Buy
68
iShares US Pharmaceuticals ETF (IHE) is a Buy

Is iShares US Pharmaceuticals ETF overpriced?

  • iShares US Pharmaceuticals ETF has risen higher in 14 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 73.68%

iShares US Pharmaceuticals ETF Stock Price History

Is IHE stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IHE is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
86.28
52-Week Low:
58.97

Prediction Charts

Market Cap:
0
Price in USD:
84.26
Volume:
66.2K
Beta:
0.69

Technical Analysis

SMA50:
79.44
SMA100:
74.90
SMA200:
70.68
52-Wk Change:
28.46%

Stock Predictions

  • Is iShares US Pharmaceuticals ETF stock public?
    Yes, iShares US Pharmaceuticals ETF is a publicly traded company.
  • What is the iShares US Pharmaceuticals ETF stock quote today?
    The iShares US Pharmaceuticals ETF stock price is 84.26 USD today.
  • How to buy iShares US Pharmaceuticals ETF stock online?
    You can buy iShares US Pharmaceuticals ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-1 85.05 84.18 85.40 84.18
Dec-2 84.03 83.34 84.31 83.30
Dec-3 83.58 83.80 84.10 83.54
Dec-4 83.67 83.06 83.67 82.86
Dec-5 83.45 83.07 83.47 82.97
Dec-8 83.66 83.11 83.66 83.01
Dec-9 83.54 81.99 83.85 81.92
Dec-10 82.11 83.40 83.50 81.95
Dec-11 84.06 84.11 84.73 83.40
Dec-12 84.33 84.81 84.89 84.24
Dec-15 85.03 86.08 86.28 85.03
Dec-16 85.91 84.51 85.91 83.80
Dec-17 84.59 84.10 84.83 84.10
Dec-18 84.10 84.26 85.15 84.10

iShares US Pharmaceuticals ETF Earnings

Data Unavailable

iShares US Pharmaceuticals ETF Forecast Revenue Growth

Data Unavailable

* iShares US Pharmaceuticals ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.